storm
[용어속성] Term
The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic
Review
[키워드] “cytokine storm”
affected
alveolar edema
characterized
clinical
Clinical outcome
Clinical severity
Complication
COVID-19
Cytokine storm
determine
disorder
H1N1
H1N1 influenza
Hemostasis
Human
hypoxia
immune dysregulation
immune response
involved
mechanism
MERS
Multiorgan dysfunction
Pandemics
Pathogenesis
Potential
respiratory
Respiratory disease
respiratory diseases
respiratory viral
Respiratory virus infections
role
SARS
Spanish flu
storm
Symptoms
systemic inflammation
the cytokine storm
triggered
[DOI] 10.3390/biomedicines9111688 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/biomedicines9111688 PMC 바로가기 [Article Type] Review
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
Immunology
[키워드] activate
Activation
acute lung injury
acute respiratory distress
acute respiratory syndrome
affected
Anti-inflammatory
anti-inflammatory effect
antibody
ARDS
B-cell
Beta blockers
carotid
chemosensory
Complication
coronavirus
coronavirus disease
cross
Cytokine storm
Effect
exaggerated immune response
hypoxia
Inflammation
Interaction
Invasion
macrophage activation
management
manifestation
mitigate
MOF
multi-organ failure
NF-κB
oxidative stress
pandemic
pathway
patients
pharmacology and Covid
potential mechanism
pro-inflammatory cytokine
pro-inflammatory cytokines
Prospective Study
reduction
respiratory
SARS-CoV-2
SARS-COV-2 infection
Severe case
signaling pathway
storm
sympathetic storm
syndrome
the SARS-CoV-2
Trigger
virus
β-blocker
[DOI] 10.3389/fimmu.2021.749291 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.749291 PMC 바로가기 [Article Type] Immunology
Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients
COVID-19 환자의 사이토카인 폭풍에 대한 기본 예측 위험 요소
Observational Study
[키워드] Absolute lymphocyte count
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
age
Anti-inflammatory therapy
basic
C-reactive protein
caused
Chest
chest computed tomographic
city
clinical and biochemical prognostic factors
clinical assessment
coronavirus
coronavirus disease
Coronavirus disease 2019
Course
COVID-19
COVID-19 patient
COVID-19 patients
Critical
CRP
cytokine
Cytokine storm
Cytokine storms
Cytokines
D-dimer
Diagnosis
disease
dysregulation
ECG
Electrocardiography
Factor
ferritin
Gender
greater
high risk
identify
IL-6
IL-6 levels
immune dysregulation
Inflammatory response
institution
interleukin
lab
laboratory biomarker
laboratory biomarkers
Lactate
lactate dehydrogenase
LDH
leads
less
lymphocyte
male
material
medical record
medical records
men
objective
overproduction
Pathogenesis
Patient
patients
patients with moderate
performed
positive test result
prognostic
prognostic biomarker
Prognostic biomarkers
prognostic scale
proinflammatory cytokines
replicative
respiratory
Result
risk
risk factor
RNA
routine clinical practice
SARS-CoV-2
score
serum
serum CRP
Serum IL-6
severe disease
state
storm
suggested
test result
Treatment
two groups
was used
women
[DOI] 10.3389/fimmu.2021.745515 PMC 바로가기 [Article Type] Observational Study
[DOI] 10.3389/fimmu.2021.745515 PMC 바로가기 [Article Type] Observational Study
Neurological Presentations in Patients with COVID-19 in Cytokine Storm
Original Article
Published on
Journal: The Canadian Journal of Neurological Sciences. Le [Category] COVID-19, MERS, SARS,
Journal: The Canadian Journal of Neurological Sciences. Le [Category] COVID-19, MERS, SARS,
[키워드] affecting
Altered
Altered level of consciousness
cause
Clinical symptoms
comparable
Coronavirus disease 2019
COVID-19
CRP
Cytokine storm
D-dimer level
elevated
ferritin
Frequency
headache
high mortality
Hospitalized
IL-6
in both group
independent risk factor
Infection
Inflammatory
intensive care
interleukin-6
intubation
Lymphocyte count
marker
moderate-to-severe COVID-19 patients
mortality rate
neurological
Neurological disorder
Neurological disorders
neurological manifestation
Neurological symptom
Patient
patients
patients with COVID-19
presentation
procalcitonin
radiological
storm
study population
two group
variety
with COVID-19
[DOI] 10.1017/cjn.2021.247 PMC 바로가기 [Article Type] Original Article
[DOI] 10.1017/cjn.2021.247 PMC 바로가기 [Article Type] Original Article
CytoSorb® Hemoadsorption as a Promising Tool to Handle COVID-19-Induced Cytokine Storm
Case Report
[키워드] accompanied
capillary leakage
Case report
Combination
Cytokine release syndrome
Cytokine storm
Cytokine storm syndrome
develop
Evidence
extracorporeal therapy
handle
hemoadsorption
hemodynamic
hemodynamic instability
hyperinflammation
Hyperinflammatory
IMPROVE
initiated
Lung function
organ injury
Patient
patient subgroup
recent
renal
severe ARDS
severe COVID-19
storm
therapy
Treatment
[DOI] 10.1155/2021/9937499 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1155/2021/9937499 PMC 바로가기 [Article Type] Case Report
Discrimination of COVID-19 From Inflammation-Induced Cytokine Storm Syndromes Using Disease-Related Blood Biomarkers
질병 관련 혈액 바이오마커를 사용한 염증 유발 사이토카인 폭풍 증후군과 COVID-19의 구별
Article
[키워드] Activation
Adhesion Molecule
association
Biomarker
Biomarkers
Characteristics
classic
condition
correlation
correlations
Course
COVID-19
Critical
cytokine
Cytokine storm
discrimination
disease
drugs targeting
dysregulation
Efficacy
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
healthy control
healthy controls
hemophagocytic lymphohistiocytosis
high mortality
HLH
hyperinflammation
IL-1
IL-1 receptor antagonist
IL-8
immune activation
immune dysregulation
intercellular
intercellular adhesion molecule
interferon
interleukin
Interleukin-18
Level
longitudinal samples
Macrophage
macrophage activation syndrome
measurement
Novel coronavirus
novel coronavirus SARS-CoV-2
observation
occur
outcome
pathway
Pathways
Patient
patients
patients with COVID-19
performed
profile
quantified
receptor antagonist
reduced
SARS-COV-2 infection
secondary hemophagocytic lymphohistiocytosis
Serum level
serum levels
serum sample
serum samples
severe COVID-19
soluble Fas ligand
storm
subgroup of patients
systemic cytokine
systemic hyperinflammation
thought
Treatment
treatment of COVID-19
Trigger
triggers
were assessed
[DOI] 10.1002/art.41763 PMC 바로가기 [Article Type] Article
[DOI] 10.1002/art.41763 PMC 바로가기 [Article Type] Article
From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry
Article
[키워드] acute respiratory syndrome
analyzed
Anti-inflammatory
anti-inflammatory activity
anti-inflammatory proteins
anti-SARS-CoV-2 vaccines
Autoimmune
characterized
coronavirus
cross-reaction
cross-reactive
cross-reactivity
Cytokine storm
Cytokine storms
disorder
Endothelial dysfunction
epitope
ferritinemia
highlight
Human
hyperinflammation
immune system
immunologic imprinting
immunological
individual
Infection
Innate immunity
macrophage activation syndrome
memory
mimicry
molecular
molecular mimicry
Multiorgan
occur
pathogen
pathogenic
pentapeptide
peptide
potential mechanism
Protein
response
responses
SARS-CoV-2
SARS-CoV-2 spike gp
spike glycoprotein
storm
Support
the cytokine storm
the SARS-CoV-2
vaccinal
[DOI] 10.3390/antib10040036 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/antib10040036 PMC 바로가기 [Article Type] Article
The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases
Case Report
[키워드] activate
Activation
acute phase
acute respiratory syndrome
addition
Adhesion Molecule
administration
adopted
alteration
anti-inflammatory properties
Anticoagulant
anticoagulant therapy
Anticoagulants
blood chemistry
cardiovascular risk
Cell
characterized
circulating
clinical
clinical expression
Coagulation
coagulation cascade
Coagulation factors
coagulation parameter
Coagulopathy
complicate
component
Coronavirus-2
COVID-19
COVID-19 patient
COVID-19 patients
criteria
cross-talk
cytokine
cytokine expression
Cytokines
death rate
Disseminated intravascular coagulation
DOAC
DOACs
Efficacy
endothelial damage
evaluate
factor Xa
Growth factors
IMPROVE
Inflammation
Inflammatory
inhibit
leucocyte
LMWH
Local
long-COVID-19
oral anticoagulant
outcomes
PARs
Patient
patients
persistence
PF4
Platelet
promote inflammation
prothrombotic state
receptor
SARS-CoV-2
storm
suggested
Survivors
Symptom
syndrome
target
thrombin
Treatment
Venous Thromboembolism
VTE
[DOI] 10.3390/v13101904 PMC 바로가기 [Article Type] Case Report
[DOI] 10.3390/v13101904 PMC 바로가기 [Article Type] Case Report
Immunotherapy Summary for Cytokine Storm in COVID-19
Pharmacology
[키워드] Activation
acute respiratory syndrome
alleviate
applied
caused
clinical effectiveness
clinically
coronavirus
COVID-19
cytokine inhibitors
Cytokine storm
deaths
drug
effective
hormone
immune
Immune cell
immunomodulatory therapy
Immunotherapy
Infection
inhibit
lack
monoclonal antibody
neutralize
Novel coronavirus
Pathogenesis
Pneumonia
Respiratory Support
resulting
SARS-CoV-2
Side effect
storm
syndrome
systemic inflammatory response
the cytokine storm
thought
Treatment
Vaccine
[DOI] 10.3389/fphar.2021.731847 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2021.731847 PMC 바로가기 [Article Type] Pharmacology